Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery

Medical Mycology

Volumn 45, Issue 2, 2007, Pages 183-185

  Revankar, Sanjay G ^a,b   Hasan, M Shahbaz ^a,b   Smith, James W ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Cerebral zygomycosis; Liposomal amphotericin B

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; INSULIN; NAPROXEN; TIMENTIN;

ADULT; ARTICLE; BRAIN INFECTION; BRAIN SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG RESPONSE; GLASGOW COMA SCALE; HEADACHE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LUMBAR PUNCTURE; LUNG ABSCESS; LUNG LAVAGE; MALE; MUCORMYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RHIZOPUS; SINUSITIS; THORAX PAIN; THORAX RADIOGRAPHY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; ZYGOMYCOSIS;

EID: 33847760974     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780601113733     Document Type: Article

References (6)

1. Gonzalez, CE, Rinaldi, MG and Sugar, AM. (2002) Zygomycosis. Infect Dis Clin N Am, 16, pp. 895-914.
2. Roden, MM, Zaoutis, TE and Buchanan, WL (2005) Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis, 41, pp. 634-653.
3. Walsh, TJ, Goodman, JL and Pappas, P. (2001) Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother, 45, pp. 3487-3496.
4. Ibrahim, AS, Avanessian, V. and Spellberg, B. (2003) Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob Agents Chemother, 47, pp. 3343-3344.
5. Groll, AH, Giri, N. and Petraitis, V. (2000) Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis, 182, pp. 274-282.
6. Greenberg, RN, Mullane, K. and van Burik, JA (2006) Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother, 50, pp. 126-133.